Hadasit Bio (Israel) Financial Indicators Patterns

HDST -- Israel Stock  

ILS 482.30  8.00  1.63%

We strongly advise you to harness Hadasit Bio fundamental analysis to see if markets are presently mispricing the organization. In other words you can makes use of it to find out if Hadasit Bio Holdings is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found twenty-nine available reported financial drivers for Hadasit Bio Holdings which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Hadasit Bio fundamentals including its Shares Outstanding, Price to Book, Revenue, as well as the relationship between Price to Earning and Price to Sales . Use Hadasit Bio to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of Hadasit Bio to be traded at S467.83 in 30 days

Hadasit Bio Company Summary

Hadasit Bio competes with Bezeq Israel, Oil Refineries, Perrigo Company, Bank Leumi, and Israel Chemicals. Hadasit Bio-Holdings, Ltd., through its subsidiaries, engages in the research and development in medical and biotechnology fields in Israel. Hadasit Bio-Holdings, Ltd. was founded in 2005 and is based in Jerusalem, Israel. Hadasit Bio operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange.

Hadasit Bio EBITDA vs Current Asset

Hadasit Bio Holdings Ltd is rated below average in ebitda category among related companies. It is rated below average in current asset category among related companies .

Hadasit Bio Market Fundamentals

 Change(%) 1.63%

Distress Rating

Hadasit Bio Financial Distress Probability

Chance of Financial Distress
Hadasit Bio Holdings Ltd has less than 3 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Hadasit Bio

Compare Hadasit Bio To Peers

Hadasit Bio Opportunity Range

October 17, 2018 Opportunity Range

Please also check Risk vs Return Analysis. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Search macroaxis.com